Sociodemographic, functional and clinical correlates in outpatients with schizophrenia: comparison with affective disorders

References

• World Health Organization. The world health report 2001: mental health: new understanding, new hope. GenevaSwitzerland: World Health Organization, 2001.
   Google Scholar
• Murray CJ, Lopez AD. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996.
   Google Scholar
• Bowie C, Beck S, Bevan G, Raftery J, Silverton F, Stevens A. Estimating the burden of disease in an English region. J Public Health Med 1997; 19: 87–92
   PubMedGoogle Scholar
• Vos T, Mathers CD. The burden of mental disorders: a comparison of methods between the Australian burden of disease studies and the Global Burden of Disease study. Bull World Health Organ 2000; 78: 427–438
   PubMed Web of Science ®Google Scholar
• Noordsy D, Torrey W, Mueser K, Mead S, O'Keefe C, Fox L. Recovery from severe mental illness: an intrapersonal and functional outcome definition. Int Rev Psychiatry 2002; 14: 318–326
   Web of Science ®Google Scholar
• Lehman AF. The well-being of chronic mental patients. Arch Gen Psychiatry 1983; 40: 369–373
   PubMed Web of Science ®Google Scholar
• Ministry of Health. Looking forward: strategic directions for the mental health services. Wellington: Ministry of Health, 1994.
   Google Scholar
• The Mental Health Commission. Blueprint for mental health services in New Zealand. How things need to be. Wellington: Mental Health Commission, 1998.
   Google Scholar
• Wilson J. Mental health services in New Zealand. Int J LawPsychiatry 2000; 23: 215–228
   PubMed Web of Science ®Google Scholar
• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005; 39:1–30.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health. Schizophrenia: core interventions in the treatment of schizophrenia in primary and secondary care. Clinical guideline 1. London: National Institute for Clinical Excellence, 2002.
   Google Scholar
• Gureje O, Herrman H, Harvey C, Morgan V, Jablensky A. The Australian National Survey of Psychotic Disorders: profile of psychosocial disability and its risk factors. Psychol Med 2002; 32: 639–647
   PubMed Web of Science ®Google Scholar
• Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 2004; 20: 139–154
   PubMed Web of Science ®Google Scholar
• Wheeler A, Humberstone V, Robinson G. Trends in antipsychotic prescribing in schizophrenia in Auckland. Australas Psychiatry 2006; 14: 169–174
   PubMedGoogle Scholar
• Walker RA. 2001 Demographic profile for counties Manukau District Health Board: an analysis of 2001 census. Regional Decision Support Team, Northern DHB Support Agency (NDSA), Auckland 2002
   Google Scholar
• Walker RA. 2001 Demographic profile for Waitemata District Health Board: an analysis of 2001 census. Regional Decision Support Team, Northern DHB Support Agency (NDSA), Auckland 2002
   Google Scholar
• Walker RA. 2001 Demographic profile for Auckland District Health Board: an analysis of 2001 census. Regional Decision Support Team, Northern DHB Support Agency (NDSA), Auckland 2002
   Google Scholar
• Walker RA. 2001 Demographic profile for Northland District Health Board: an analysis of 2001 census. Regional Decision Support Team, Northern DHB Support Agency (NDSA), Auckland 2002
   Google Scholar
• Humberstone V, Wheeler A, Lambert T. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand. Aust N Z J Psychiatry 2004; 38: 240–245
   PubMed Web of Science ®Google Scholar
• Statistics New Zealand. Census: National summary (2001) – reference report. Wellington: Statistics New Zealand, 2001. Available from URL: http://www.stats.gov.nz./census/2001-censes-data/2001-national-summary/default.htm.
   Google Scholar
• Bailey D. A users guide to the Mental Health (Compulsory Assessment and Treatment) Act. Department of Health, Wellington 1992
   Google Scholar
• Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 1988; 45: 79–91
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical Evidence (NICE). Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. London: National Institute for Clinical Evidence, 2002.
   Google Scholar
• Evert H, Harvey C, Trauer T, Herrman H. The relationship between social networks and occupational and self-care functioning in people with psychosis. Soc Psychiatry Psychiatr Epidemiol 2003; 38: 180–188
   PubMed Web of Science ®Google Scholar
• Hansson L, Middelboe T, Sorgaard KW, et al. Living situation, subjective quality of life and social network among individuals with schizophrenia living in community settings. Acta Psychiatr Scand 2002; 106: 343–350
   PubMed Web of Science ®Google Scholar
• Ochoa S, Haro JM, Autonell J, et al. Met and unmet needs of schizophrenia patients in a Spanish sample. Schizophr Bull 2003; 29: 201–210
   PubMed Web of Science ®Google Scholar
• Thornicroft G, Tansella M, Becker T, et al. The personal impact of schizophrenia in Europe. Schizophr Res 2004; 69: 125–132
   PubMed Web of Science ®Google Scholar
• Tanzman B. An overview of surveys of mental health consumers’ preferences for housing and support services. Hosp Community Psychiatry 1993; 44: 450–455
   PubMedGoogle Scholar
• Owen C, Rutherford V, Jones M, Wright C, Tennant C, Smallman A. Housing accommodation preferences of people with psychiatric disabilities. Psychiatr Serv 1996; 47: 628–632
   PubMed Web of Science ®Google Scholar
• Dickerson FB, Sommerville J, Origoni AE, Ringel NB, Parente F. Outpatients with schizophrenia and bipolar I disorder: do they differ in their cognitive and social functioning?. Psychiatry Res 2001; 102: 21–27
   PubMed Web of Science ®Google Scholar
• Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004; 161: 1–56
   PubMed Web of Science ®Google Scholar
• Andrews G, Sanderson K, Corry J, Issakidis C, Lapsley H. Cost-effectiveness of current and optimal treatment for schizophrenia. Br J Psychiatry 2003; 183: 427–435
   PubMed Web of Science ®Google Scholar
• Mental Health Commission. Our Lives in 2014: a recovery vision from people with experience of mental illness for the second mental health plan and the development of the health and social sectors. Wellington: Mental Health Commission, 2004.
   Google Scholar